KCK LTD.
CIK
1657662
Location
TORTOLA, D8
Portfolio Value
Micro
$15,075,494
Diversification
Highly concentrated
Filing Date
Global Rank
#7,439
/ 7,986
▼ 135
· as of Sep 2025
Top Industry
Medical Devices
99.8%
3Y Alpha vs SPY
+17.4%
Period ended 9 months ago
Filed Oct 14, 2025 · 9mo
12 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+163.8%
SPY
+76.0%
Annualised alpha
+17.4%
Max drawdown
−61.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
2 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
99.8%
+0.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
9,966
Highly concentrated+1
Portfolio Trend
12 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $15,075,494 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
2 positions ·
$15,075,494 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SGHT |
Sight Sciences, Inc.
Healthcare
|
Held | 4,374,975 | $15,049,914 | 99.83% | |
| RNTX |
Rein Therapeutics, Inc.
Healthcare
|
Held | 22,341 | $25,580 | 0.17% |